Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000598255 | SCV000706302 | likely benign | not specified | 2017-02-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000868210 | SCV001009513 | benign | Autosomal recessive polycystic kidney disease | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002483622 | SCV002800522 | likely benign | Polycystic kidney disease 4 | 2021-12-23 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000868210 | SCV002081010 | likely benign | Autosomal recessive polycystic kidney disease | 2017-10-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003945411 | SCV004761532 | likely benign | PKHD1-related disorder | 2021-07-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |